Your shopping cart is currently empty

Copper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo. Copper histidine is administered orally for the treatment of Menkes disease.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $76 | In Stock | In Stock | |
| 5 mg | $177 | In Stock | In Stock | |
| 10 mg | $260 | In Stock | In Stock | |
| 25 mg | $506 | In Stock | In Stock | |
| 50 mg | $690 | In Stock | In Stock | |
| 100 mg | $982 | In Stock | In Stock | |
| 500 mg | $1,970 | - | In Stock |
| Description | Copper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo. Copper histidine is administered orally for the treatment of Menkes disease. |
| In vitro | Copper histidine (10 lmol/L) inhibited cellular uptake of oxaliplatin mediated by Ctr1 in HEK293 cells overexpressing rat Ctr1.[1] |
| Molecular Weight | 217.69 |
| Formula | C6H8CuN3O2 |
| Cas No. | 77280-83-2 |
| Smiles | O=C1[O-][Cu+2]2[N]3(C(C[C@@]1([NH2]2)[H])=CN=C3)[H] |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: < 1 mg/mL (insoluble or slightly soluble) |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.